Clinical trial for Depressive Disorder, Treatment-Resistant
Official title rTMS With and Without Text4Support for the Treatment of Resistant Depression.
ClinicalTrials.gov ID: NCT05570344
What this study is testing
- What it's testing
- The study wants to see if combining rTMS with a text‑message support program improves depression outcomes compared to rTMS alone.
- Who it's for
- Adults who have depression that has not improved with other treatments.
- What's involved
- Participants receive rTMS sessions over six weeks. One group also gets regular supportive text messages; the other group gets only the rTMS. After treatment, they are checked at 1, 3, and 6 months.
- Time commitment
- The study lasts about 12 months, including six weeks of treatment and follow‑up visits at 1, 3, and 6 months after treatment ends.
- Time commitment: about 12 months
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- aged 18 and above and diagnosed with MDD based upon the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and who have at...
You likely can't join if
- Patients below the age of 18.
- Having diagnosis such as the following conditions (current unless otherwise stated): A neurological disorder, including a history of seizures, having...
- Having a current psychotic disorder such as substance-induced psychosis, psychotic disorder due to a medical condition, or MDD with psychotic...
- Having a current personality disorder that may hinder the patient's participation in this research or may have the potential of affecting cognition...
- Having a learning disability as per identified through medical history or by the investigator during the assessment process.
- Participants involved in any drug or device clinical trial within the last six weeks before the screening visit and/or involvement in another...
See the full eligibility criteria
- aged 18 and above and diagnosed with MDD based upon the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and who have at least failed two or more standard antidepressant treatments during...
- Patients below the age of 18.
- Having diagnosis such as the following conditions (current unless otherwise stated): A neurological disorder, including a history of seizures, having primary or secondary tumors in the central nervous system...
- Having a current psychotic disorder such as substance-induced psychosis, psychotic disorder due to a medical condition, or MDD with psychotic features at the time of screening
- Having a current personality disorder that may hinder the patient's participation in this research or may have the potential of affecting cognition and ability to fully participate in the study.
- Having a learning disability as per identified through medical history or by the investigator during the assessment process.
- Participants involved in any drug or device clinical trial within the last six weeks before the screening visit and/or involvement in another clinical trial for the duration of this study.
- Pregnant and breastfeeding women.
- Identification and/or the sudden appearance of any condition or instance from the mentioned above and based on the expertise of the investigators that have the potential to hinder the progress and completion and/or...
The study team makes the final eligibility decision.
Where it is enrolling
- Edmonton, Alberta, Canada
- Halifax, Nova Scotia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Edmonton, Alberta, Canada; Halifax, Nova Scotia, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.